Results 31 to 40 of about 47,826 (191)

Cardiomyopathies de l'enfant [PDF]

, 2022
Les cardiomyopathies sont des maladies peu répandues et ceci est d’autant plus vrai chez les enfants. La cardiomyopathie dilatée est la forme la plus courante des cardiomyopathies.
Bendahane, Hamza Zohir, Kazi Aoual, Mohammed Ali   +1 more
core  

Cardiomyocyte dysfunction in inherited cardiomyopathies

, 2021
Inherited cardiomyopathies form a heterogenous group of disorders that affect the structure and function of the heart. Defects in the genes encoding sarcomeric proteins are associated with various perturbations that induce contractile dysfunction and ...
Mügge, Andreas (Prof. Dr. med.), Budde, Heidi (M. Sc.), Hamdani, Nazha (Dr. med.), Hassoun, Roua (M. Sc.)   +3 more
core   +3 more sources

Assessing the Applicability of Cardiac Myosin Inhibitors for Hypertrophic Cardiomyopathy Management in a Large Single Center Cohort

Reviews in Cardiovascular Medicine
Background: Cardiac myosin inhibitors (CMIs), including Mavacamten and Aficamten, have emerged as a groundbreaking treatment for hypertrophic cardiomyopathy (HCM).
Ali Amr, Elham Kayvanpour, Christoph Reich, Jan Koelemen, Shamily Asokan, Norbert Frey, Benjamin Meder, Farbod Sedaghat-Hamedani   +7 more
doaj   +1 more source

Human-induced pluripotent stem cells in modeling inherited cardiomyopathies

Journal of the Practice of Cardiovascular Sciences, 2015
Our current understanding of molecular mechanisms of cardiomyopathies has been elucidated from genetic animal models. Induced pluripotent stem cells (iPSCs) can provide a platform to improve our understanding of familial cardiomyopathies diseases.
Subhoshree Ghose, Anju Sharma, Aishwarya Agarwal, Shantanu Sengupta   +3 more
doaj   +1 more source

Eclipsed Functional Mitral Regurgitation Destabilizing Hypertrophic Cardiomyopathy: An Unusual Case Treated With MitraClipNovel Teaching Points

CJC Open, 2021
MitraClip (Abbott Laboratories, Abbott Park, IL) is validated in high-risk patients with severe degenerative mitral regurgitation (MR); however, it is not well established for functional MR in hypertrophic cardiomyopathy (HCM).
Catherine Bourque, MD, Marina Dijos, MD, Lionel Leroux, MD, Louis Labrousse, MD, Alexandre Metras, MD, Matthieu Michaud, MD, Marie Hébert, MD, Patricia Réant, MD, Stéphane Lafitte, MD   +8 more
doaj   +1 more source

Pediatric Cardiomyopathies

, 2017
Pediatric cardiomyopathies are rare diseases with an annual incidence of 1.1 to 1.5 per 100 000. Dilated and hypertrophic cardiomyopathies are the most common; restrictive, noncompaction, and mixed cardiomyopathies occur infrequently; and arrhythmogenic ...
Thrush, Philip T, Stephanie M. Ware, Wendy K. Chung, Steven D. Colan, Paul Kantor, Kantor, Paul, Daphne T. Hsu, Czachor, Jason D, Rossano, Joseph W, Castleberry, Chesney D, Addonizio, Linda J, Hiedy Razoky, Erin M. Miller, Lamour, Jacqueline M, Miller, Erin M, Lipshultz, Steven E, Steven E. Lipshultz, Teresa M. Lee, Towbin, Jeffrey A, Jeffrey A. Towbin, Ashley Hill, Jacqueline M. Lamour, Colan, Steven D, Joseph W. Rossano, Razoky, Hiedy, Jason D. Czachor, Jefferies, John L, Hsu, Daphne T, Hill, Ashley, Lal, Ashwin K, Linda J. Addonizio, John L. Jefferies, Philip T. Thrush, Chesney D. Castleberry, Lee, Teresa M, Ware, Stephanie M, Ashwin K. Lal, Chung, Wendy K   +37 more
core   +1 more source

A very rare cause of pre‐capillary pulmonary hypertension: The PAMI syndrome

Pulmonary Circulation, 2023
We report the first known case of PAMI syndrome associated with pulmonary arterial hypertension (PAH) with a positive response to cyclophosphamide and pulmonary vasodilators. The patient's history began at 7 months with severe pancytopenia and fever.
Manuela Iseppi, Giulio Savonitto, Alberto Tommasini, Alessia Pin, Gianfranco Sinagra, Davide Stolfo   +5 more
doaj   +1 more source

Targeting ferroptosis as a promising therapeutic strategy to treat cardiomyopathy

Frontiers in Pharmacology, 2023
Cardiomyopathies are a clinically heterogeneous group of cardiac diseases characterized by heart muscle damage, resulting in myocardium disorders, diminished cardiac function, heart failure, and even sudden cardiac death.
Huiyan Sun, Huiyan Sun, Dandan Chen, Wenjing Xin, Lixue Ren, Qiang LI, Xuchen Han   +6 more
doaj   +1 more source

Cardiomyopathies

, 2013
The disease of the heart muscle may occur secondarily to common diseases, such as ischemic, hypertensive and valvular, among others. However, there is a group of conditions with intrinsic myocardial involvement from gene or multifactorial etiology, and ...

core   +1 more source